Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms.

Neumann D, Tschernig T, Popa D, Schmiedl A, Pérez de Lema G, Resch K, Martin MU.

Int Immunol. 2006 Dec;18(12):1779-87. Epub 2006 Oct 31.

PMID:
17077176
2.

IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.

Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, Ueda A, Shirai A, Okuda K, Miyazaki J, Ishigatsubo Y.

Cytokine. 2000 Jul;12(7):1035-41.

PMID:
10880249
3.

Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain.

Neumann D, Del Giudice E, Ciaramella A, Boraschi D, Bossù P.

J Immunol. 2001 Mar 15;166(6):3757-62.

4.
5.
6.

A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease.

Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, Komai-Koma M, Wei X, Liew FY.

J Immunol. 2001 Nov 1;167(9):5338-47.

7.

In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr/lpr mice.

Hecht M, Müller M, Lohmann-Matthes ML, Emmendörffer A.

J Leukoc Biol. 1995 Feb;57(2):242-9.

PMID:
7852838
8.

Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.

Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.

Arthritis Rheum. 2002 Nov;46(11):3083-95.

9.

Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice.

Hefeneider SH, Conlon PJ, Dower SK, Henney CS, Gillis S.

J Immunol. 1984 Apr;132(4):1863-8.

PMID:
6607951
10.

Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).

Katzav A, Kloog Y, Korczyn AD, Niv H, Karussis DM, Wang N, Rabinowitz R, Blank M, Shoenfeld Y, Chapman J.

Clin Exp Immunol. 2001 Dec;126(3):570-7.

12.

Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).

Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S.

Clin Exp Immunol. 1995 Apr;100(1):111-7.

13.

Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.

Anam K, Amare M, Naik S, Szabo KA, Davis TA.

Lupus. 2009 Apr;18(4):318-31. doi: 10.1177/0961203308097479.

PMID:
19276300
14.

Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).

Sugiyama N, Nakashima H, Yoshimura T, Sadanaga A, Shimizu S, Masutani K, Igawa T, Akahoshi M, Miyake K, Takeda A, Yoshimura A, Hamano S, Yoshida H.

Ann Rheum Dis. 2008 Oct;67(10):1461-7. Epub 2007 Dec 18.

15.

Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.

Fan JL, Himeno K, Tsuru S, Nomoto K.

Clin Exp Immunol. 1987 Oct;70(1):94-101.

16.

The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice.

Hong YH, Huang CJ, Wang SC, Lin BF.

Lupus. 2009 Mar;18(3):206-15. doi: 10.1177/0961203308095450.

PMID:
19213858
18.

The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.

Apelgren LD, Bailey DL, Fouts RL, Short L, Bryan N, Evans GF, Sandusky GE, Zuckerman SH, Glasebrook A, Bumol TF.

Cell Immunol. 1996 Oct 10;173(1):55-63.

PMID:
8871601
19.

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.

Bossù P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G, Dinarello CA, Di Carlo E, Musiani P, Meroni PL, Caselli G, Ruggiero P, Boraschi D.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14181-6. Epub 2003 Nov 13.

Supplemental Content

Support Center